$CNC (+1,34Â %)
$CI (-0,85Â %)
$OSCR
$UNH (-1,86Â %)
$HUM (+0,54Â %)
$CVS (+0,65Â %)
$CNC (+1,34Â %) Centene has withdrawn its earnings guidance for 2025 after new data showed significantly higher morbidity and lower than expected growth in the Marketplace business. This resulted in a decline in net revenue from risk adjustment of approximately $1.8 billion and a decline in earnings of approximately $2.75 per share. Medicaid costs are also rising, particularly in the areas of mental health, home care and expensive drugs in states such as New York and Florida. $CNC (+1,34Â %) plans a price correction for 2026 and will provide more information in its Q2 results on July 25.
Oscar Health $OSCR is also down due to its high presence in this area, as are other insurance stocks such as $HUM (+0,54Â %) , $CI (-0,85Â %) and $UNH (-1,86Â %) . $CNC (+1,34Â %) will announce further details on its Q2 results on July 25.
Centene $CNC (+1,34Â %) has withdrawn its forecast for 2025 due to rising ACA/Medicaid costs. (The Affordable Care Act (ACA), also known as ObamacareACA) accounts for 72% of the business of $CNC (+1,34Â %) business.
$UNH (-1,86Â %) has withdrawn from many ACA markets and it now accounts for only a small part of their business.
$CNC (+1,34Â %) also reported that Medicare Advantage plans are doing better than expected, could be a positive for $UNH (-1,86Â %) positive as many people now have to self-insure.
